Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | VIKING THERAPEUTICS INC | $3.34B | -71.30% | -65.30% | -94.11% | -84.60% | 0.21 | 5.72 | N/A | N/A | N/A | ||
| EQT | EQT CORP | $32.49B | 14.10% | 8.00% | 11.97% | 10.70% | 0.51 | 0.66 | 78.60% | 31.90% | 45.79% | ||
| BNTX | BIONTECH SE | $21.73B | -6.70% | -5.80% | -5.83% | -12.80% | 0.13 | 8.80 | 77.60% | -44.60% | -40.14% | ||
| SLDB | SOLID BIOSCIENCES INC | $702.93M | -74.50% | -62.00% | -48.85% | -120.70% | 0.13 | 13.10 | N/A | N/A | N/A | ||
| PCVX | VAXCYTE INC | $6.85B | -32.50% | -29.50% | -30.47% | -33.20% | 0.12 | 7.49 | N/A | N/A | N/A | ||
| CGEM | CULLINAN THERAPEUTICS INC | $841.98M | -51.80% | -47.90% | -60.09% | -63.60% | 0.10 | 10.28 | N/A | N/A | N/A | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $997.52M | -25.90% | -22.80% | -24.27% | -23.30% | 0.21 | 1.10 | 79.00% | -49.40% | -47.66% | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $336.44M | -41.80% | -34.60% | -29.42% | -50.50% | 0.18 | 8.75 | 100.00% | -17,982.70% | -18,053.88% | ||
| ODTX | ODYSSEY THERAPEUTICS INC | N/A | N/A | N/A | -61.47% | N/A | -0.11 | 7.20 | 100.00% | -4,994.90% | -5,025.44% | ||
| KLRA | KAILERA THERAPEUTICS INC | $2.45B | N/A | N/A | N/A | N/A | -0.15 | 9.67 | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.